Ignite Creation Date:
2025-12-25 @ 5:12 AM
Ignite Modification Date:
2025-12-26 @ 4:17 AM
Study NCT ID:
NCT04162327
Status:
COMPLETED
Last Update Posted:
2023-10-24
First Post:
2019-10-31
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase Ia/Ib Study of IBI315 in Patients With HER2-expressing Advanced Solid Tumor
Sponsor:
Innovent Biologics (Suzhou) Co. Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-26
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-20
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-31
First Submit QC Date:
None
Study First Post Date:
2019-11-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-22
Last Update Post Date:
2023-10-24
Last Update Post Date Type:
ACTUAL